Analyst Consensus ?
ConsensusBuy14 ratings
Bullish964.3%
Neutral535.7%
Bearish00.0%
Credicorp Ltd. · BAP · FY2024 Q3 · Calendar Q4 2024
Credicorp posts strong Q3 while loan growth remains constrained
The transcript supports a constructive but qualified view: strong profitability, improving asset quality and digital-platform growth provide support, while near-zero loan growth, rate sensitivity and capital or regulatory constraints temper the outlook.
Reported After market closeNYSEFinancial Services
$29.40B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$5.08
Consensus $4.57
EPS surprise
+11.2%
Reported versus consensus
Reported revenue
—
Consensus $1.42B
Revenue surprise
—
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
+1.4%
Event window
SPY move
+0.4%
Same window
Abnormal move
+1.0%
Stock minus SPY
Volume
1.4×
Versus trailing sessions
Subsequent drift
+3.2%
Up to 20 sessions
BAPSPY benchmark
Ask FN2 about BAP FY2024 Q3
Transcript, numbers and history already loaded
Why did BAP rise 1.4% after beating EPS estimates in FY2024 Q3?What changed in BAP's guidance and outlook in FY2024 Q3?Give me the bull and bear case for BAP after FY2024 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The current analysis adds record profitability with improved asset quality, provisional approval for Tenpo Bank Chile, and the planned acquisition of the remaining BanMedica stake. Guidance was maintained, while loan growth remained near zero and management continued to flag rate, capital and regulatory sensitivities.
Guidance delta
Maintained: GDP growth guidance at 3%, loan growth near 0%, net interest margin at the upper end of 6%-6.4%, and return on equity around 17%.
Key takeaways
- Management described record net income and 18.5% ROE, alongside improved asset quality.
- Yape and Tenpo continued to support transaction growth and revenue diversification.
- Management maintained its macro, loan-growth, net-interest-margin, and ROE guidance.
- Tenpo Bank Chile approval and the BanMedica stake acquisition were the main strategic developments.
Management priorities
- Advance Tenpo Bank Chile toward full operational authorization.
- Grow Yape users and increase revenue per user.
- Complete and integrate the remaining BanMedica joint-venture acquisition.
- Continue digital-transformation and efficiency investments while targeting lower-end efficiency-ratio guidance.
Follow BAP with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$370.21Current
$154Low
$323.71Average
$480High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 26, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Overweight | Neutral | Upgrade | Sep 16, 2026 |
| UBS | Buy | Buy | Maintain | Aug 20, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jul 16, 2026 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Jun 17, 2026 |
| HSBC | Buy | Hold | Upgrade | May 19, 2026 |
| Citigroup | Buy | Buy | Maintain | Aug 20, 2025 |
| B of A Securities | Neutral | Buy | Downgrade | Dec 16, 2024 |
| Scotiabank | Sector Outperform | Sector Perform | Upgrade | Jul 7, 2023 |
| Itau BBA | Outperform | Market Perform | Upgrade | Jan 3, 2023 |
| Credit Suisse | Outperform | Neutral | Upgrade | Jul 19, 2022 |
| Santander | Hold | Buy | Downgrade | Jun 23, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Jan 7, 2020 |
| Barclays | Overweight | Overweight | Maintain | Mar 15, 2016 |
| Raymond James | Market Perform | Outperform | Downgrade | Mar 15, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $370.21. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Thiago Batista | $473 | $368.98 | +27.8% | Aug 20, 2026 |
| Morgan Stanley | Jorge Kuri | $480 | $364.28 | +29.7% | Jun 17, 2026 |
| UBS | Analyst unavailable | $412 | $342.85 | +11.3% | May 26, 2026 |
| HSBC | Carlos Gomez-Lopez | $350 | $303.86 | -5.5% | May 19, 2026 |
| UBS | Thiago Batista | $408 | $340.01 | +10.2% | Apr 21, 2026 |
| UBS | Thiago Batista | $318 | $267.1 | -14.1% | Sep 16, 2025 |
| Morgan Stanley | Jorge Kuri | $195 | $185 | -47.3% | Sep 27, 2024 |
| Bank of America Securities | Ernesto Gabilondo | $190 | $185 | -48.7% | Sep 27, 2024 |
| Bradesco | Gustavo Schroden | $207 | $161.88 | -44.1% | Apr 18, 2024 |
| BTG Pactual | Alonso Aramburu | $154 | $129.38 | -58.4% | Sep 9, 2022 |
Track every rating change on BAP the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCredicorp Ltd., together with its subsidiaries, provides various banking services and products in Peru, Bermuda, Colombia, Bolivia, Panama, Chile, the United States, the Cayman Islands, and Mexico. It operates through Universal Banking; Insurance, Medical Services, and Pensions; Microfinance; and Investment Management and Advisory segments. The company grants various credits and financial instruments to individuals and legal entities; and various deposits and current accounts. It also issues insurance policies to cover losses in commercial property, transport, marine vessels, automobiles, life, health, and pensions; provides medical and health services, as well as management services of private pension funds to the affiliates.…
Historical context
All BAP earningsFinancial Services peers this season
Latest reports in the same sector
Latest beats and misses
Who reports nextBeat on EPS
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
- FCNCNFY2026 Q3 · October 23, 2026+19.9% EPS+0.2% move
- FCNCOFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- FCNCPFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- RDYFY2027 Q2 · October 23, 2026+24.0% EPS-0.2% move
- SLBFY2026 Q3 · October 23, 2026+3.7% EPS+7.1% move
Missed on EPS
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
- SPOTFY2026 Q3 · October 22, 2026-11.6% EPS+11.1% move
- VRSNFY2026 Q3 · October 22, 2026-2.0% EPS-0.9% move
- HBANMFY2026 Q3 · October 22, 2026-5.3% EPS+0.5% move
Get the BAP recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-10T18:38:36.707185+00:00
- Polygon adjusted daily market bars · 2026-10-26T01:20:44.207045+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-26T01:20:44.204222+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-26. For educational purposes only; not investment advice.